Browsing publications by Dr Daniel Williamson

Newcastle AuthorsTitleYearFull text
Dr Janet Lindsey
Dr Ed Schwalbe
Sandeep Potluri
Professor Simon Bailey
Dr Daniel Williamson
et al.
TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours2014
Professor Simon Bailey
Professor Steven Clifford
Dr Daniel Williamson
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group2014
Dr Klaus Rehe
Kerrie Wilson
Dr Simon Bomken
Dr Daniel Williamson
Dr Julie Irving
et al.
Acute B lymphoblastic leukaemia-propagating cells are present at high frequency in diverse lymphoblast populations2013
Dr Ed Schwalbe
Dr Daniel Williamson
Dr Janet Lindsey
Dolores Hamilton
Sarra Ryan
et al.
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies2013
Dr Daniel Williamson
HES6 enhances the motility of alveolar rhabdomyosarcoma cells2013
Dr Daniel Williamson
Professor Olaf Heidenreich
Identification of a Dynamic Core Transcriptional Regulatory Network for t(8;21) AML2013
Dr Matthew Allen
Dr Daniel Williamson
Professor Steven Clifford
Inhibiting Polo-like kinase 1 causes growth reduction and apoptosis in pediatric acute lymphoblastic leukemia cells2013
Dr Sarra Ryan
Dr Ed Schwalbe
Mike Cole
Yuan Lu
Dr Meryl Lusher
et al.
MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma2012
Dr Daniel Williamson
PAX3/FOXO1 Fusion Gene Status is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification2012
Dr Daniel Williamson
Professor Steven Clifford
A significant proportion of medulloblastoma do not sub-group robustly: Identification of a molecular NOS (not otherwise specified) subgroup2012
123